Andlauer Healthcare Group (TSE:AND – Get Free Report) had its price objective dropped by CIBC from C$52.00 to C$50.00 in a report issued on Monday, BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. CIBC’s price objective would indicate a potential upside of 24.22% from the company’s previous close.
AND has been the subject of several other research reports. Eight Capital decreased their price objective on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a “buy” rating for the company in a report on Thursday, March 7th. TD Securities lowered their price objective on shares of Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a research note on Monday. Royal Bank of Canada lowered their price target on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating for the company in a research report on Monday. National Bankshares lifted their price objective on Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the stock a “sector perform” rating in a report on Thursday, March 7th. Finally, Scotiabank boosted their price target on Andlauer Healthcare Group from C$45.00 to C$47.50 and gave the stock a “sector perform” rating in a report on Thursday, March 7th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Andlauer Healthcare Group has an average rating of “Moderate Buy” and a consensus target price of C$49.43.
Check Out Our Latest Research Report on Andlauer Healthcare Group
Andlauer Healthcare Group Stock Down 1.9 %
Andlauer Healthcare Group (TSE:AND – Get Free Report) last released its earnings results on Tuesday, March 5th. The company reported C$0.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.49 by C($0.05). The business had revenue of C$169.07 million during the quarter, compared to the consensus estimate of C$165.00 million. Andlauer Healthcare Group had a net margin of 10.21% and a return on equity of 14.53%. On average, sell-side analysts forecast that Andlauer Healthcare Group will post 1.8439434 EPS for the current fiscal year.
About Andlauer Healthcare Group
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Further Reading
- Five stocks we like better than Andlauer Healthcare Group
- Best Stocks Under $5.00
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Value Stocks You Can Buy Before They Become Big
- Using the MarketBeat Dividend Tax Calculator
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.